The Trump administration's pledge to contain long-term U.S. Treasury yields has strengthened bond market expectations that a ...
Deutsche Bank upgraded West Pharmaceutical (WST) to Buy from Hold with a price target of $250, down from $275. The company’s Q4 results and a ...
Deutsche Bank downgraded Informatica (INFA) to Hold from Buy with a $21 price target The firm cites the company’s “disappointing” Q4 results ...
Deutsche Bank, Germany’s largest financial institution, has partnered with Swiss crypto company Taurus and launched a ...
UBS’s stock is now worth buying, after tumbling following the Swiss banking giant’s fourth-quarter earnings report, Deutsche ...
Investing.com -- The dot com bubble of the late 1990s was a period of extraordinary growth and speculation in technology ...
Deutsche Bank AG was fined €10 million ($10.3 million) by Spain’s securities regulator CNMV for selling derivatives to ...
Deutsche Bank Aktiengesellschaft's Q4 results showed an 8.6% revenue increase but a 17% drop in pre-tax profit. Click here to find out why DB stock is a Buy.
The bank on Thursday ditched its closely watched cost target for 2025, saying it wanted to make investments in business. It now aims for a cost-to-income ratio of below 65%, compared with previous ...
Deutsche Bank Aktiengesellschaft assumed coverage on shares of Praxis Precision Medicines (NASDAQ:PRAX – Free Report) in a ...
Deutsche Bank’s shift to Google Cloud powers up its AI capabilities, optimising operations and slashing process times ...
Spanish supervisors said on Monday they had fined Germany's Deutsche Bank 10 million euros ($10.32 million) for infringements ...